Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanja van Geel

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Dermatologic Clinics|March 21, 2017
Segmental VitiligoNanja van Geel, Reinhart Speeckaert
American Journal of Clinical Dermatology|June 4, 2017
Vitiligo: An Update on Pathophysiology and Treatment OptionsReinhart Speeckaert, Nanja van Geel
Experimental Dermatology|May 20, 2016
Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligoReinhart Speeckaert, Nanja van Geel
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2023
The real-life efficacy of methotrexate in vitiligo: A retrospective study and literature reviewReinhart Speeckaert, Nanja van Geel
European Journal of Dermatology : EJD|October 27, 2021
What vitiligo patients want to know outside the dermatologist's office: an analysis of online search behaviourReinhart Speeckaert, Nanja Van Geel
Journal of the American Academy of Dermatology|October 23, 2023
Ultraviolet photography in vitiligo using a smartphone camera attachment for checking sunscreen coverageReinhart Speeckaert, Nanja van Geel
Clinical and Experimental Dermatology|August 22, 2024
Repigmentation in facial vitiligo depends on the affected areasReinhart Speeckaert, Lu Wang, Nanja van Geel
Frontiers in Immunology|August 15, 2022
From IL-17 to IFN-γ in inflammatory skin disorders: Is transdifferentiation a potential treatment target?Arno Belpaire, Nanja van Geel, Reinhart Speeckaert
The Journal of Investigative Dermatology|January 15, 2016
Measuring the Impact of Vitiligo: Behind the White SpotsReinhart Speeckaert, Jo Lambert, Nanja van Geel
Frontiers in Immunology|August 24, 2019
Learning From Success and Failure: Biologics for Non-approved Skin DiseasesReinhart Speeckaert, Jo Lambert, Nanja van Geel
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Dermatologic Clinics|March 21, 2017
Segmental VitiligoNanja van Geel, Reinhart Speeckaert
American Journal of Clinical Dermatology|June 4, 2017
Vitiligo: An Update on Pathophysiology and Treatment OptionsReinhart Speeckaert, Nanja van Geel
Experimental Dermatology|May 20, 2016
Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligoReinhart Speeckaert, Nanja van Geel
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2023
The real-life efficacy of methotrexate in vitiligo: A retrospective study and literature reviewReinhart Speeckaert, Nanja van Geel
European Journal of Dermatology : EJD|October 27, 2021
What vitiligo patients want to know outside the dermatologist's office: an analysis of online search behaviourReinhart Speeckaert, Nanja Van Geel
Journal of the American Academy of Dermatology|October 23, 2023
Ultraviolet photography in vitiligo using a smartphone camera attachment for checking sunscreen coverageReinhart Speeckaert, Nanja van Geel
Clinical and Experimental Dermatology|August 22, 2024
Repigmentation in facial vitiligo depends on the affected areasReinhart Speeckaert, Lu Wang, Nanja van Geel
Frontiers in Immunology|August 15, 2022
From IL-17 to IFN-γ in inflammatory skin disorders: Is transdifferentiation a potential treatment target?Arno Belpaire, Nanja van Geel, Reinhart Speeckaert
The Journal of Investigative Dermatology|January 15, 2016
Measuring the Impact of Vitiligo: Behind the White SpotsReinhart Speeckaert, Jo Lambert, Nanja van Geel
Frontiers in Immunology|August 24, 2019
Learning From Success and Failure: Biologics for Non-approved Skin DiseasesReinhart Speeckaert, Jo Lambert, Nanja van Geel
Pageof 10